Clinica Universidad Navarra

Madrid 28027

0 studies enrolling now · 2 studies all time

What they study most

Early Breast Cancer, Select Advanced Solid Tumors

Studies at this site

• A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) — Running, not enrolling
• Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab — Withdrawn before enrolling